Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

50.77 -0.32 (-0.63%)
Official Closing Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 719,765
Open 51.15
Bid (Size) 49.42 (1)
Ask (Size) 53.43 (1)
Prev. Close 51.09
Today's Range 50.68 - 51.47
52wk Range 48.86 - 80.04
Shares Outstanding 100,460,697
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
Stifel analyst Mathew Blackman upgraded Globus Medical, Inc. (NYSE: GMED) to Buy from Hold, 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Via Benzinga

Performance

YTD
-30.60%
-30.60%
1 Month
-6.10%
-6.10%
3 Month
-13.11%
-13.11%
6 Month
-4.46%
-4.46%
1 Year
-12.07%
-12.07%

More News

Read More
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
From Globus Medical
Via GlobeNewswire
The Latest Analyst Ratings for Globus Medical
Via Benzinga
Where Globus Medical Stands With Analysts
Via Benzinga
Globus Medical (GMED) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Globus Medical Completes Merger with NuVasive
From Globus Medical
Via GlobeNewswire
Globus Medical Reports Second Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
From Globus Medical
Via GlobeNewswire
Expert Ratings for Globus Medical
Via Benzinga
Analyst Expectations for Globus Medical's Future
Via Benzinga
Globus Medical (GMED) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Globus Medical: Q1 Earnings Insights
Via Benzinga
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Globus Medical Announces FDA Approval for its Non-Fusion Scoliosis Correction System, the Latest Advancement for Young Patients with Idiopathic Scoliosis
From Globus Medical
Via GlobeNewswire
Globus Medical Reports First Quarter 2023 Results
From Globus Medical
Via GlobeNewswire
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules First Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
7 Stocks to Buy with Bulletproof Balance Sheets
Via InvestorPlace
Minimally Invasive Surgery — This Company's Successful Trial Could Help Eliminate The Need For An Incision In Patients With Back Pain
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Via Benzinga
Inflation, TikTok, and Other Hot Stories Investors Are Talking About
Via The Motley Fool
Top 5 Health Care Stocks That May Rocket Higher In Q1 2023
Via Benzinga
Globus Medical (GMED) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.